Medical Scientist Training Program

医学科学家培训计划

基本信息

  • 批准号:
    10620999
  • 负责人:
  • 金额:
    $ 92.89万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-07-01 至 2028-06-30
  • 项目状态:
    未结题

项目摘要

This proposal requests support for the MSTP at the University of Cincinnati College of Medicine (UCCOM). Our dual-degree program was established in 1985 and has been continuously NIH-funded for over 20 years. It enrolls 9 new students each year and currently includes 73 students. A unique and central feature of our program is that our MSTP is a partnership between a top ranked college of medicine and a premier children's hospital (Cincinnati Children's Hospital). The atmosphere afforded by seamless alignment of research and clinical practice provides the ideal research environment for significant and impactful health related research. The overarching mission of the UCCOM MSTP is to recruit, mentor, and educate a diverse group of physician scientists who will become leaders in their chosen careers that integrate clinical medicine and research to advance clinically relevant science and improve health throughout the world. Our Program is supported by a solid infrastructure in clinical and research training. Our students can choose from 11 diverse graduate programs. The success of our Program is best illustrated by the success of our graduates. Our students come from a diverse applicant pool drawn from across the nation. For the class that matriculated in the Fall of 2021. we had 189 applicants, which included applications from 37 states, Washington DC, and Puerto Rico. Our current MSTP students include 12% URM. The average time to complete our MSTP for the last 10 years is 8.0 years and our students have matched at the most competitive residency programs. Since the last funding period, several important and exciting developments have taken place, which include increases in the size and quality of our applicant pool including URM and disabled/disadvantaged applicants, our program faculty, extramural research support among our program faculty, number and breadth of training opportunities for MD/PhD candidates, increased individualized advising, expanded multi-pronged mentoring approaches, implementation of significant DEi initiatives including efforts designed to increase recruitment and retention of URI/M, disabled and disadvantaged students, expansion of both UCCOM and CCHMC facilities, and implementation of evidence based approaches to mentoring including required mentor training for all participating faculty. We are confident that we can continue to achieve our aims and meet the central goal of our program. Towards this goal, we are requesting support for 18 positions.
该提案请求支持辛辛那提大学医学院(UCCOM)的MSTP。我们的双学位课程成立于1985年,并已连续NIH资助超过20年。它每年招收9名新生,目前有73名学生。我们的计划的一个独特和中心的特点是,我们的MSTP是一个顶尖的医学院和首屈一指的儿童医院(辛辛那提儿童医院)之间的合作伙伴关系。研究和临床实践的无缝结合所提供的氛围为重要和有影响力的健康相关研究提供了理想的研究环境。UCCOM MSTP的首要使命是招募,指导和教育一群多样化的医生科学家,他们将成为他们所选择的职业的领导者,将临床医学和研究结合起来,以推进临床相关科学并改善世界各地的健康。 我们的计划得到了临床和研究培训方面坚实基础设施的支持。我们的学生可以从11个不同的研究生课程中选择。我们计划的成功最好地说明了我们的毕业生的成功。我们的学生来自全国各地的多元化申请人。在2021年秋季入学的班级。我们有189名申请者,其中包括来自37个州、华盛顿特区和波多黎各的申请者。我们目前的MSTP学生包括12%的URM。在过去的10年里,完成MSTP的平均时间是8.0年,我们的学生在最具竞争力的居住计划中名列前茅。 自上一个资助期以来,已经发生了几个重要和令人兴奋的发展,其中包括我们的申请人池的规模和质量的增加,包括URM和残疾人/弱势申请人,我们的计划教师,我们的计划教师之间的校外研究支持,MD/博士候选人的培训机会的数量和广度,增加个性化咨询,扩大多管齐下的指导方法,实施重大的DEi举措,包括旨在增加URI/M,残疾和弱势学生的招聘和保留,扩大UCCOM和CCHMC设施,以及实施基于证据的指导方法,包括所有参与教师的必要导师培训。我们相信,我们能够继续实现我们的目标,实现我们计划的中心目标。为了实现这一目标,我们请求支持18个职位。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Gurjit K. Khurana Hershey其他文献

Frequent exacerbator—a novel endotype of pediatric asthma
  • DOI:
    10.1016/j.jaci.2025.05.006
  • 发表时间:
    2025-07-01
  • 期刊:
  • 影响因子:
    11.200
  • 作者:
    Kieran J. Phelan;Gurjit K. Khurana Hershey
  • 通讯作者:
    Gurjit K. Khurana Hershey
emTSLP/em disease-associated genetic variants combined with airway TSLP expression influence asthma risk
  • DOI:
    10.1016/j.jaci.2021.05.033
  • 发表时间:
    2022-01-01
  • 期刊:
  • 影响因子:
    11.200
  • 作者:
    Liza Bronner Murrison;Xiaomeng Ren;Kristina Preusse;Hua He;John Kroner;Xiaoting Chen;Seth Jenkins;Elisabet Johansson;Jocelyn M. Biagini;Matthew T. Weirauch;Raphael Kopan;Lisa J. Martin;Gurjit K. Khurana Hershey
  • 通讯作者:
    Gurjit K. Khurana Hershey
Rhinoconjunctivitis symptoms in children and adolescents with asthma: Longitudinal clustering analysis
哮喘儿童和青少年的鼻结膜炎症状:纵向聚类分析
  • DOI:
    10.1016/j.jaci.2024.12.1084
  • 发表时间:
    2025-05-01
  • 期刊:
  • 影响因子:
    11.200
  • 作者:
    Alkis Togias;Peter J. Gergen;Andrew H. Liu;Haejin Kim;Robert A. Wood;George T. O’Connor;Melanie Makhija;Gurjit K. Khurana Hershey;Carolyn M. Kercsmar;Rebecca S. Gruchalla;Carin Lamm;Leonard B. Bacharier;Shilpa J. Patel;James E. Gern;Daniel J. Jackson;Cynthia M. Visness;Agustin Calatroni;William W. Busse
  • 通讯作者:
    William W. Busse
Biomarker-driven drug development for allergic diseases and asthma: An FDA public workshop
针对过敏性疾病和哮喘的生物标志物驱动的药物开发:FDA 公共研讨会
  • DOI:
    10.1016/j.jaci.2025.03.014
  • 发表时间:
    2025-06-01
  • 期刊:
  • 影响因子:
    11.200
  • 作者:
    Ronald L. Rabin;Matthew C. Altman;S. Hasan Arshad;Richard D. Beger;Pamela A. Frischmeyer-Guerrerio;Elena Goleva;Robert G. Hamilton;Gurjit K. Khurana Hershey;Mohamed H. Shamji;Hugh A. Sampson;Alexandra F. Santos;Wayne G. Shreffler;Alkis Togias;Stefan Vieths;Erik Wambre;Sally E. Wenzel;Kathleen Hise;Joohee Lee;Anubha Tripathi;Jay E. Slater
  • 通讯作者:
    Jay E. Slater
High number of early respiratory infections in association with allergic sensitization to mold promotes childhood asthma
  • DOI:
    10.1016/j.jaci.2017.11.058
  • 发表时间:
    2018-05-01
  • 期刊:
  • 影响因子:
  • 作者:
    Leilanie Perez Ramirez;Heepke Wendroth;Lisa J. Martin;Valentina V. Pilipenko;Hua He;John Kroner;Patrick H. Ryan;Grace K. LeMasters;James E. Lockey;David I. Bernstein;Gurjit K. Khurana Hershey;Jocelyn M. Biagini Myers
  • 通讯作者:
    Jocelyn M. Biagini Myers

Gurjit K. Khurana Hershey的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Gurjit K. Khurana Hershey', 18)}}的其他基金

Multi-omics of the Frequent Exacerbator Asthmatic
频繁加重哮喘的多组学
  • 批准号:
    10197294
  • 财政年份:
    2021
  • 资助金额:
    $ 92.89万
  • 项目类别:
Multi-omics of the Frequent Exacerbator Asthmatic
频繁加重哮喘的多组学
  • 批准号:
    10596089
  • 财政年份:
    2021
  • 资助金额:
    $ 92.89万
  • 项目类别:
Multi-omics of the Frequent Exacerbator Asthmatic
频繁加重哮喘的多组学
  • 批准号:
    10390405
  • 财政年份:
    2021
  • 资助金额:
    $ 92.89万
  • 项目类别:
Atopic dermatitis: mechanisms of disease progression
特应性皮炎:疾病进展的机制
  • 批准号:
    10379962
  • 财政年份:
    2020
  • 资助金额:
    $ 92.89万
  • 项目类别:
Atopic dermatitis: mechanisms of disease progression
特应性皮炎:疾病进展的机制
  • 批准号:
    10596577
  • 财政年份:
    2020
  • 资助金额:
    $ 92.89万
  • 项目类别:
Atopic dermatitis: mechanisms of disease progression
特应性皮炎:疾病进展的机制
  • 批准号:
    9974832
  • 财政年份:
    2020
  • 资助金额:
    $ 92.89万
  • 项目类别:
Role and Regulation of TSLP in Childhood Allergic Disease
TSLP在儿童过敏性疾病中的作用和调节
  • 批准号:
    10307538
  • 财政年份:
    2017
  • 资助金额:
    $ 92.89万
  • 项目类别:
Role and Regulation of TSLP in Childhood Allergic Disease
TSLP在儿童过敏性疾病中的作用和调节
  • 批准号:
    10063471
  • 财政年份:
    2017
  • 资助金额:
    $ 92.89万
  • 项目类别:
Infrastructure and Opportunity Fund Management
基础设施和机会基金管理
  • 批准号:
    8329216
  • 财政年份:
    2011
  • 资助金额:
    $ 92.89万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    8196249
  • 财政年份:
    2011
  • 资助金额:
    $ 92.89万
  • 项目类别:

相似海外基金

Polar Early Career Chief Scientist Training Program
Polar 早期职业首席科学家培训计划
  • 批准号:
    2401176
  • 财政年份:
    2024
  • 资助金额:
    $ 92.89万
  • 项目类别:
    Standard Grant
Collaborative Research: Sharing Scientist Role Model Stories to Improve Equity and Success in Undergraduate STEM Education
合作研究:分享科学家榜样故事,以提高本科 STEM 教育的公平性和成功率
  • 批准号:
    2337064
  • 财政年份:
    2024
  • 资助金额:
    $ 92.89万
  • 项目类别:
    Standard Grant
Collaborative Research: Sharing Scientist Role Model Stories to Improve Equity and Success in Undergraduate STEM Education
合作研究:分享科学家榜样故事,以提高本科 STEM 教育的公平性和成功率
  • 批准号:
    2337063
  • 财政年份:
    2024
  • 资助金额:
    $ 92.89万
  • 项目类别:
    Standard Grant
CAREER: Scientist-in-the-loop-software testing
职业:科学家在环软件测试
  • 批准号:
    2339830
  • 财政年份:
    2024
  • 资助金额:
    $ 92.89万
  • 项目类别:
    Continuing Grant
Surgeon-Scientist Research Training in Injury Pathobiology and Outcomes In Critical Illness
外科医生科学家损伤病理学和危重疾病结果研究培训
  • 批准号:
    10555523
  • 财政年份:
    2023
  • 资助金额:
    $ 92.89万
  • 项目类别:
BLRD Research Career Scientist Award Application
BLRD 研究职业科学家奖申请
  • 批准号:
    10582394
  • 财政年份:
    2023
  • 资助金额:
    $ 92.89万
  • 项目类别:
CSRD Research Career Scientist Award Application
CSRD研究职业科学家奖申请
  • 批准号:
    10701136
  • 财政年份:
    2023
  • 资助金额:
    $ 92.89万
  • 项目类别:
BLRD Research Career Scientist Award Application
BLRD 研究职业科学家奖申请
  • 批准号:
    10702045
  • 财政年份:
    2023
  • 资助金额:
    $ 92.89万
  • 项目类别:
Medical Scientist Training Program at Tufts University
塔夫茨大学医学科学家培训项目
  • 批准号:
    10626366
  • 财政年份:
    2023
  • 资助金额:
    $ 92.89万
  • 项目类别:
University of Utah Medical Scientist Training Program
犹他大学医学科学家培训计划
  • 批准号:
    10628815
  • 财政年份:
    2023
  • 资助金额:
    $ 92.89万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了